Pharmaceuticals

Global Myocardial Infarction Drugs Market 2016-2020

  • TEC443036
  • 75 Pages
  • March 2016
  • Pharmaceuticals
About Myocardial Infarction Drugs

Myocardial infarction, commonly known as heart attack, is the irreparable death of the heart tissue. It occurs when blood stops flowing to a part of the myocardium (heart muscle), depriving it of oxygen and nutrients. If the coronary artery that supplies blood to the heart muscle is blocked by the formation of plaque (a substance made of fat, cholesterol, and cellular waste), the heart is starved of oxygen, a condition called cardiac ischemia, causing tissue damage. Cardiac ischemia may lead to episodes of angina or chest pain. The slow build-up of plaque on the walls of the heart narrows the blood vessels and finally blocks them. Rapid flow of lipids through the vessels may also create a tear on the walls of the vessels causing aggregation of platelets and the formation of a clot. The clot formation causes obstruction of blood supply through the vessels, leading to necrosis or the death of tissues in the heart muscle.

Technavios analysts forecast the global myocardial infarction drugs market to grow at a CAGR of 0.41% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global myocardial infarction drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used for the treatment and prevention of myocardial infarction.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Myocardial Infarction Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AstraZeneca
Bayer HealthCare
Eli Lilly
Novartis
Pfizer
Sanofi

Other prominent vendors
advanceCOR
Armaron Bio
Athersys
BioVascular
BMS
Caladrius
Capricor
CSL Behring
GNT Pharma
GSK
Ischemix
Mesoblast
NeuroVive
Osiris Therapeutics
PledPharma
RegeneRx
Teva Pharmaceuticals
TiGenix
US Stem Cell
Ventrix

Market driver
Growing older population
For a full, detailed list, view our report

Market challenge
Alternative therapies
For a full, detailed list, view our report

Market trend
Growing awareness of disease
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

RNA-Based Therapeutics Asia-Pacific Market Research Report, 2014 - 2021

The RNA-based therapeutics involves broad range of the RNA-based technologies, which help the patients to diagnose or treat various chronic diseases. The RNA-based therapeutics play a crucial role in providing ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global anxiety disorders and depression treatment Market (Drug Class, Pipeline Analysis and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Depression and anxiety disorders are the most common psychiatric disorders affecting a huge population across the globe. Depression; is related to a state of emotion that further affects actions, thoughts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Smoking Cessation and Nicotine De-Addiction Products Market (Product Type and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Smoking cessation or nicotine de-addiction involves tobacco discontinuation. Tobacco contains nicotine that causes addiction by releasing the neurotransmitters such as glutamate, dopamine and gamma-aminobutyric acid (GABA). Cigarette and tobacco addicts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Injectable Drug Delivery Market (Formulation, Device, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Injectable drug delivery system is infusion method, which administers drug into body by piercing the skin with the help of syringe attached to the needle. Most popular route it follows ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Clinical Nutrition Market - Opportunities and Forecast, 2014 - 2020

Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>